# US 7,745,155 B2 · In-vivo monitoring of circulating apoptotic cells

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 7,745,155 B2
- Document ID: US7745155B2
- Status: Granted
- Kind: B2
- Application number: 11/190,729
- Filed: 2005-07-27
- Published: 2006-06-22
- Granted: 2010-06-29
- Earliest claimed: 2004-12-17
- Assignees: Massachusetts General Hospital
- Inventors: Charles P. Lin; Xunbin Wei; Dorothy Sipkins
- Web page: https://patentgrep.com/patent/US7745155B2

## CPC

- A61K 49/0032: {Methine dyes, e.g. cyanine dyes}
- A61K 49/0056: {Peptides, proteins, polyamino acids}
- A61K 49/0097: {Cells, viruses, ghosts, red blood cells, viral vectors, used for imaging or diagnosis in vivo}
- G01N 33/56966: {Animal cells}
- G01N 33/57595: {involving intracellular compounds}
- G01N 33/582: {with fluorescent label}
- G01N 2510/00: Detection of programmed cell death, i.e. apoptosis
- G01N 2800/52: Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
- Y10T 436/101666: Particle count or volume standard or control [e.g., platelet count standards, etc.]
- Y10T 436/13: Tracers or tags
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- Y10T: TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION

## Abstract

The present invention provides methods and systems for performing in vivo flow cytometry. In one embodiments, selected circulating cells of interest of a subject are labeled with fluorescent probe molecules. The labeled cells are irradiated in-vivo so as to excite the fluorescent probes, and the radiation emitted by the excited probes is detected, preferably confocally. The detected radiation is then analyzed to derive desired information, such as relative cell count, of the cells of interest. In some embodiments, the circulating cells comprise apoptotic cells whose detection can allow, e.g., non-invasive monitoring of the efficacy of a cancer treatment, such as an anti-tumor or an anti-angiogenic therapy.

## Claims

### Claim 1

A method for non-invasive detection of non-viable cells in a subject using in-vivo flow cytometry, comprising
labeling a plurality of non-viable cells circulating in a circulatory system of the subject with one or more fluorescent probe molecules that bind to the non-viable cells while the non-viable cells circulate in the circulatory system of the subject,
illuminating the labeled cells in-vivo with radiation having one or more wavelength components suitable for exciting said one or more fluorescent probe molecules,
detecting fluorescence radiation emitted by the labeled cells in response to said excitation, and
analyzing said detected fluorescence radiation so as to count labeled non-viable circulating cells from which fluorescence is detected.

### Claim 2 (depends on 1)

The method of claim 1, wherein said circulating non-viable cells comprise circulating apoptotic cells.

### Claim 3 (depends on 2)

The method of claim 2, wherein said apoptotic cells comprise endothelial apoptotic cells.

### Claim 4 (depends on 1)

The method of claim 1, wherein said illuminating and detecting steps are performed confocally.

### Claim 5 (depends on 1)

The method of claim 1, wherein said count of labeled cells provides a count of said non-viable cells relative to a previously-obtained count of non-viable cells from the subject.

### Claim 6 (depends on 1)

The method of claim 1, wherein said illuminating step comprises exposing said labeled cells to radiation having one or more wavelength components in a range of about 400 nm to about 1000 nm.

### Claim 7 (depends on 1)

The method of claim 1, wherein said one or more fluorescent robe molecules comprises a molecule suitable for coupling to a cell surface marker of the non-viable cells.

### Claim 8 (depends on 7)

The method of claim 7, wherein said one or more fluorescent probe molecules comprises annexin-V conjugated to Alexa Fluor 647.

### Claim 9

A method for real-time quantification of non-viable circulating cells using in-vivo flow cytometry in a live subject, comprising:
administering to a circulatory system of the subject a plurality of fluorescent probe molecules capable of coupling to a plurality of non-viable cells,
illuminating at least a portion of a blood vessel of the subject with radiation capable of exciting said fluorescent probe molecules flowing through said vessel portion,
confocally detecting fluorescence radiation originating from one or more of said excited probe molecules flowing through said vessel portion, and
analyzing said detected fluorescence to identify fluorescent signals emitted by probe molecules coupled to said non-viable circulating cells, thereby providing a count of circulating non-viable cells from which fluorescence is detected.

### Claim 10 (depends on 9)

The method of claim 9, wherein said analyzing step comprises determining a relative count of said circulating non-viable cells.

### Claim 11 (depends on 9)

The method of claim 9, wherein said non-viable cells comprise apoptotic endothelial cells.